Rep. Carol Spackman Moss (D)

HB 230 (Coverage for Eosinophilic Disorders)

Libertas Institute opposes this bill.

This bill would force insurance companies to provide coverage for the use of an amino acid-based elemental formula diagnosis or treatment of an eosinophilic gastrointestinal disorder.

Libertas Institute opposes this bill. The government has no authority to compel a private company to provide certain services to its clients.